Brace Pharma Capital participated in a round that took the total raised by the rare genetic disease drug developer to more than $85m.

The smart home device maker has raised $54.5m from investors including Baidu and Libai as it gears up for a China initial public offering.

OurCrowd has attracted support from Motorola Solutions and Reliance Industries for a seed stage incubator it launched alongside a $50m sports tech fund.

Joby Aviation has raised $100m in an Intel Capital-led series B round that included JetBlue Technology Ventures, indicating the rise in air-based corporate venturing.

Future Planet Capital is set to receive up to $200m in capital from TW & Partners for its inaugural fund.

The vehicle, which has already secured $470m in commitments, will aim to help commercialise British research and help companies expand into China.

The spinout is building drug discovery technology that uses artificial intelligence and machine learning to identify biomarkers, drug targets and pathways.

The University of Waterloo spinout has been backed by university-linked investors as it prepares to expand its range of biosensor nanotechnology products.

Sundt and Canica participated in industrial technology developer Arundo Analytics' latest round, which will fund hiring, sales and marketing.